We report potent inhibition of the 
function of RII concentration. The results suggest that RII both inhibits the active phosphatase and inhibits phosphatase activation. The inhibition is shown to be noncompetitive with respect to substrate (phosphorylase a). The potential physiological significance of this inhibition is discussed in terms of phosphorylation/dephosphorylation cascade systems involving this kinase and phosphatase.
In recent years, increasing attention has been focused on uncovering the role of protein phosphatases in regulating the state ofphosphorylation of various proteins and enzymes that control an array of cellular processes. It is known that reversible, protein phosphorylation/dephosphorylation is an important general mechanism of regulating diverse cellular processes in response to various physiological stimuli (1, 2) .
The identification of protein kinases acting in protein phosphorylation cascades and the mechanisms by which they are regulated via second messengers such as cAMP and Ca2' have preceded similar knowledge ofthe protein phosphatases involved. Recently, Ingebritsen and Cohen (3, 4) have attempted to categorize a variety of protein phosphatase forms identified in different systems as being one of four different classes of enzymes. In the nomenclature of Ingebritsen and Cohen (3, 4) , type 1 protein phosphatase has been shown to be inhibited by two different heat-stable protein inhibitors termed inhibitor 1 
and inhibitor 2 (5-9).
A Mg(I)*ATP-dependent protein phosphatase has been isolated fr6m rabbit skeletal muscle and characterized (10, 11) . This enzyme is a major phosphorylase phosphatase in skeletal muscle and it also readily dephosphorylates the ,B subunit of phosphorylase kinase as well as glycogen synthase (10, 12) , suggesting an important role in the glycogen cascade system. The enzyme, isolated in its inactive form, is activated by kinase FA (also identified as glycogen synthase kinase 3) in the presence of Mg(II)-ATP (13, 14) . Inhibitor 2, also termed modulator, M, has been identified as a modulator of this phosphatase (9) . It is now considered to be a subunit of the enzyme that has been designated Fc-M. Recent work on the mechanism of activation of this phosphatase by kinase FA has implicated phosphorylation/dephosphorylation of modulator in the interconversion of active and inactive phosphatase (15) . A similar enzymatic activity has been isolated from rabbit skeletal muscle by a procedure involving an acetoneprecipitation step (16, 17 [y32P]ATP was purchased from New England Nuclear. Phosphorylase b was isolated from rabbit skeletal muscle and converted to 32P-labeled phosphorylase a as described (20, 21) . Phosphatase Fc-M and kinase FA were isolated as described (10, 13) . Two different preparations of phosphatase Fc-M were tested for inhibition by RI' with similar findings. However, most experiments were performed by using a preparation with lower specific activity (=1,500 units/mg) compared to that described previously (10, 15) . This preparation was devoid of other known phosphorylase phosphatases, since the expression of phosphatase activity required activation by kinase FA and Mg(II).ATP. The phosphatase activity unit is defined as the amount of enzyme that releases 1 nmol of [32P]phosphate per min at 30°C from 32P-labeled phosphorylase a (2 mg/ml). Bovine heart type II cAMP-dependent protein kinase, purified as described (22) , was kindly donated by Emily Shacter (National Heart, Lung, and Blood Institute). RI' and the catalytic subunit C were isolated from porcine heart and purified to near homogeneity as described (23) .
Enzyme Assays. Assays of phosphorylase phosphatase activity were performed by using an organic extraction procedure as described (15) or with a modified extraction procedure (24) . Dephosphorylation of phosphorylase a in the assay was usually 10% or less. Biochemistry: Jurgensen et al.
The concentration of phosphorylase was determined by using the absorbance index of AIro = 13.1 (25) . The concentration of other proteins was determined by the method of Bradford (26) .
RESULTS
Identification of RII as a Phosphatase Inhibitor. The Mg(II).ATP-dependent phosphatase Fc-M is activated by kinase FA in the presence of Mg(II).ATP (13, 14) . We found that bovine heart (type II) cAMP-dependent protein kinase, when substituted for kinase FA, and in the presence of cAMP and Mg(II).ATP, was unable to activate the phosphatase.
However, including cAMP-dependent protein kinase in the activation-preincubation with kinase FA resulted in a CAMPdependent inhibition of phosphatase activity. The isolated subunits of the type II cAMP-dependent protein kinase from porcine heart were used to test whether phosphatase inhibition derived from C or RI.' C did not inhibit phosphatase activity when it was included with kinase FA and Mg(II).ATP during Fc-M activation (Fig. 1) . However, RYI did inhibit the phosphatase. Inhibition by RI' was slightly enhanced by the addition of cAMP, which by itself had no effect on phosphatase activity. The RI' preparation contained some bound nucleotide derived from the affinity purification step in which cGMP was used to elute the protein. The 32P-labeled phosphorylase a was then added, and phosphatase activity was assayed. In assays 1-3, 400 ng/ml of kinase FA (final assay concentration) was used to activate Fc-M completely. In assays 4-6, the kinase FA was reduced to 80 ng/ml, which results in 72% of the maximal activation of the phosphatase. The average of duplicate control assays in the presence of cAMP was used as the baseline activity. The values shown for assays in the presence of R' are the average of duplicates. The final assay concentrations of components other than FA were the same as in A except for RII, which was at 100 nM (10.6 Ag/ml). In the experiment presented in Fig. 1, for It is known that RI' may contain covalently bound phosphate at several different sites (27, 29) . Thus, it might be possible for RI' to inhibit phosphatase by binding at the phosphatase substrate binding site, in which case the inhibition by RI' would be expected to be competitive with respect to phosphorylase a. However, the inhibition of phosphatase by RI' was observed to be noncompetitive. The data from an initial rate kinetic experiment performed at different concentrations of RI' is shown in Fig. 5 . In the presence of RI' a decrease in the Vm,_ was observed with no effect on the Km for phosphorylase a. In addition, inhibition of phosphatase by RI' occurred with the concentration of phosphorylase a in large excess over the concentration of RI'. Together, these data indicate that the inhibition is neither due to RI' binding Biochemistry: Jurgensen et al. (Fig. 3B) may be involved in segregating responses to different stimuli, which are mediated through cAMP-dependent protein kinase (32) . We are currently investigating the possible inhibition of the Mg(II)-ATP-dependent phosphatase by the regulatory subunit of other types of cAMP-dependent protein kinase.
The role envisaged for the coordinate regulation of type II cAMP-dependent protein kinase and this phosphatase is summarized in Fig. 6 . This represents the situation for a monocyclic cascade utilizing these enzymes as converter enzymes that respectively phosphorylate and dephosphorylate the interconvertible substrate I. Increased cAMP concentration dissociates the protein kinase into its regulatory RYI and catalytic C subunits. C catalyzes phosphorylation of I, and simultaneously RI' inhibits the activated phosphatase and the activation of the phosphatase. This inhibition contributes to the increased fractional phosphorylation of I. Such a synchronous regulatory mechanism provides both signal enhancement and an enhanced sensitivity to the effector, cAMP. That is, a lower concentration of cAMP will be required to achieve an intermediate level of fractional phosphorylation, and changes in fractional phosphorylation will be more sensitive to changes in cAMP.
This effect may be multiplied further due to the fact that phosphatase Fc-M has a broad substrate specificity and dephosphorylates many of the phosphorylation sites of the phosphoproteins involved in the glycogen cascade system. Furthermore, the coincident activation of protein kinase activity and inhibition of protein phosphatase activity reduces the ATP consumption of this system, thus making it more energetically efficient (33).
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